HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Verastegui Selected Research

IRX 2

9/2007IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
8/2003A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck.
6/2002A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma.
3/2000Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Verastegui Research Topics

Disease

3Neoplasms (Cancer)
09/2007 - 03/2000
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2003 - 03/2000
2Hemorrhage
08/2003 - 06/2002
2Pain (Aches)
08/2003 - 06/2002
1Squamous Cell Neoplasms (Squamous Cell Cancer)
08/2003
1Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2002
1Carcinoma (Carcinomatosis)
06/2002
1Gastritis
03/2000
1Exanthema (Rash)
03/2000
1Squamous Cell Carcinoma of Head and Neck
03/2000
1Parotitis (Parotiditis)
03/2000

Drug/Important Bio-Agent (IBA)

4IRX 2IBA
09/2007 - 03/2000
3Indomethacin (Indometacin)FDA LinkGeneric
08/2003 - 03/2000
3CytokinesIBA
08/2003 - 03/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2003 - 03/2000
2ZincIBA
08/2003 - 03/2000

Therapy/Procedure

3Immunotherapy
08/2003 - 03/2000
2Injections
08/2003 - 06/2002
1Neoadjuvant Therapy
06/2002
1Therapeutics
03/2000